Literature DB >> 8313536

The generation of apurinic/apyrimidinic sites in isolated DNA during the reduction of chromate by glutathione.

M Casadevall1, A Kortenkamp.   

Abstract

We have obtained evidence for the induction of apurinic/apyrimidinic sites (AP-sites) in isolated DNA treated with chromate and glutathione using agents that cleave the DNA phosphate backbone at AP-sites (putrescine, Lys-Trp-Lys and exonuclease III). In the presence of glutathione (5 mM) the level of AP-sites rose with increasing concentrations of chromate (75-200 microM). Neither chromate nor glutathione alone nor the final product of the reaction between chromate and glutathione were capable of inducing the lesion. Thus, an intermediate species generated during the reduction process seems to be the cause of the damage. In view of the known mutagenicity of AP-sites our findings might be of some importance in relation to the mechanisms involved in chromate carcinogenicity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8313536     DOI: 10.1093/carcin/15.2.407

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  4 in total

Review 1.  Molecular and epigenetic mechanisms of Cr(VI)-induced carcinogenesis.

Authors:  Qiao Yi Chen; Anthony Murphy; Hong Sun; Max Costa
Journal:  Toxicol Appl Pharmacol       Date:  2019-06-20       Impact factor: 4.219

2.  Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest.

Authors:  T O'Brien; J Xu; S R Patierno
Journal:  Mol Cell Biochem       Date:  2001-06       Impact factor: 3.396

Review 3.  Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium.

Authors:  Konstantin Salnikow; Anatoly Zhitkovich
Journal:  Chem Res Toxicol       Date:  2007-10-30       Impact factor: 3.739

4.  Analysis of repair and mutagenesis of chromium-induced DNA damage in yeast, mammalian cells, and transgenic mice.

Authors:  L Cheng; S Liu; K Dixon
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.